When was SUNETIC BIOTECH's shareholders' meeting held?

It was held on June 16, 2026 (Minguo Year 115).

What was approved in this resolution?

The 2025 earnings distribution, financial statements, and charter amendment for the Hangzhou subsidiary were approved.

What does Xinghui Tianli (Hangzhou) Pharmaceutical do?

It is a local pharmaceutical subsidiary of the Xinghui Group, engaged in R&D, manufacturing, and sales in China.

Was there a director election?

No, there was no election of directors or supervisors at this meeting.

Why is this information important?

It's a major disclosure indicating the group's financial health and governance standards.

AI News NQ Analysis

[SUNETIC BIOTECH] Annual Shareholders' Meeting of Key Subsidiary SUNETIC BIOTECH INC. - Announcement of Resolutions

NQ Score 79/100

N1 Content Completeness 9

AI Summary (NQ-processed)

SUNETIC BIOTECH INC., a key subsidiary of Xinghui, held its annual shareholders' meeting on June 16, 2026, approving the 2025 earnings distribution plan, financial statements, and charter amendments for its Hangzhou subsidiary.

AI Analysis

Frequently Asked Questions

Q: When was SUNETIC BIOTECH's shareholders' meeting held?: A: It was held on June 16, 2026 (Minguo Year 115).
Q: What was approved in this resolution?: A: The 2025 earnings distribution, financial statements, and charter amendment for the Hangzhou subsidiary were approved.
Q: What does Xinghui Tianli (Hangzhou) Pharmaceutical do?: A: It is a local pharmaceutical subsidiary of the Xinghui Group, engaged in R&D, manufacturing, and sales in China.
Q: Was there a director election?: A: No, there was no election of directors or supervisors at this meeting.
Q: Why is this information important?: A: It's a major disclosure indicating the group's financial health and governance standards.